Public Engagement and Clinical Trials: New Models and Disruptive Technologies:

Workshop Summary

Status: Available Now

Size: 140 pages, 8 1/2 x 11

Publication Year:2011

Print	List Price


PAPERBACK ISBN-10: 0-309-21929-9 ISBN-13: 978-0-309-21929-7	$41.00	Add to Cart

PDF			About PDF

Authors:
Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine
Authoring Organizations

Description:

Paste into your Web page:

<!-- Start NAP Book Display -->
<object classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=8,0,0,0" width="175" height="250" id="napbookwrapper" align="middle">
<param name="allowScriptAccess" value="always" />
<param name="movie" value="http://www.nap.edu/napbookwrapper.swf" />
<param name="quality" value="high" />
<param name="wmode" value="transparent" />
<param name="flashvars" value="wid=2322761702013052144525&record_id=13237" />
<embed src="http://www.nap.edu/napbookwrapper.swf" quality="high" flashvars="wid=2322761702013052144525&record_id=13237" wmode="transparent" bgcolor="#ffffff" width="175" height="250" name="napbookwrapper" align="middle" allowScriptAccess="always" allowFullScreen="false" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"></embed>
</object>

Preview

Free Resources

Full Text
Jump to this book's table of contents to begin reading online for free.

Related Items:
Related Titles

PDF Summary
Download the summary in PDF.

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter	i-xvi
1 Introduction	1-4	(skim)
2 Framing the Problem	5-16	(skim)
3 Recruitment Challenges in Clinical Trials for Different Diseases and Conditions	17-30	(skim)
4 Models for Public Engagement	31-38	(skim)
5 Messages and Methods for Public Engagement	39-48	(skim)
6 The Media	49-54	(skim)
7 Novel Clinical Trial Designs	55-64	(skim)
8 The Health System's Structure and Culture	65-74	(skim)
9 Toward a Patient-Centered Strategy for Clinical Trials	75-84	(skim)
References	85-88	(skim)
Appendix A: Workshop Agenda	89-98	(skim)
Appendix B: The Clinical Trials Process	99-100	(skim)
Appendix C: Participant Biographies	101-124	(skim)

Description

Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.

Public Engagement and Clinical Trials: New Models and Disruptive Technologies:

Workshop Summary

Citation Manager

Description

Authoring Organizations

Search This Book

SIGN UP FOR...